CL2008003262A1 - Vacuna que comprende lactococcus garviae, pasteurella piscicida, vibrio anguillarum y nocardia seriolae; y uso de dichas bacterias para combatir infecciones de nocardia en peces. - Google Patents
Vacuna que comprende lactococcus garviae, pasteurella piscicida, vibrio anguillarum y nocardia seriolae; y uso de dichas bacterias para combatir infecciones de nocardia en peces.Info
- Publication number
- CL2008003262A1 CL2008003262A1 CL2008003262A CL2008003262A CL2008003262A1 CL 2008003262 A1 CL2008003262 A1 CL 2008003262A1 CL 2008003262 A CL2008003262 A CL 2008003262A CL 2008003262 A CL2008003262 A CL 2008003262A CL 2008003262 A1 CL2008003262 A1 CL 2008003262A1
- Authority
- CL
- Chile
- Prior art keywords
- nocardia
- seriouslae
- combat
- vaccine
- fish
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/107—Vibrio
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Mycology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Vacuna que comprende lactococcus garviae, pasteurella piscicida, vibrio anguillarum y nocardia seriolae; y uso de dichas bacterias para combatir infecciones de nocardia en peces.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP07119868 | 2007-11-02 |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2008003262A1 true CL2008003262A1 (es) | 2009-06-26 |
Family
ID=39769302
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2008003262A CL2008003262A1 (es) | 2007-11-02 | 2008-10-30 | Vacuna que comprende lactococcus garviae, pasteurella piscicida, vibrio anguillarum y nocardia seriolae; y uso de dichas bacterias para combatir infecciones de nocardia en peces. |
Country Status (5)
Country | Link |
---|---|
JP (1) | JP5175940B2 (es) |
CN (1) | CN101868248A (es) |
AU (1) | AU2008320818A1 (es) |
CL (1) | CL2008003262A1 (es) |
WO (1) | WO2009056629A1 (es) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2011073990A (ja) * | 2009-09-29 | 2011-04-14 | Meiji Seika Kaisha Ltd | 海産魚のノカルジア症に対するdnaワクチン及びbcgワクチン |
CN102166350B (zh) * | 2011-04-13 | 2012-11-21 | 中国水产科学研究院黄海水产研究所 | 鲆鲽鱼类五联灭活疫苗及其制备方法 |
CN103495159B (zh) * | 2013-09-17 | 2016-07-06 | 中国科学院水生生物研究所 | 柱状黄杆菌基因重组疫苗的制备方法 |
IL230970A0 (en) * | 2014-02-13 | 2014-09-30 | Univ Ramot | Tilapia virus vaccines |
CN104232535B (zh) * | 2014-09-02 | 2017-04-26 | 广东海洋大学 | 鰤鱼诺卡氏菌诱变弱毒株及其应用 |
CN106754488A (zh) * | 2016-11-30 | 2017-05-31 | 广西南宁市武鸣明山红农业科技开发有限公司 | 一种海豚链球菌病生物制剂及其制备方法与应用 |
CN107602685B (zh) * | 2017-11-03 | 2020-09-15 | 宁波大学 | 一种从银鲳中分离的具有抗菌性能的多肽 |
CN109880766B (zh) * | 2019-03-18 | 2021-05-07 | 宁波大学 | 一种银鲳美人鱼发光杆菌菌株及灭活疫苗 |
CN110250047B (zh) * | 2019-06-14 | 2021-12-17 | 中国水产科学研究院南海水产研究所 | 一种工厂化养殖四指马鲅的方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001342140A (ja) * | 2000-03-29 | 2001-12-11 | Gotoo Yoshoku Kenkyusho:Kk | 魚類・甲殻類用薬剤及び飼料 |
JP2001342141A (ja) * | 2000-03-29 | 2001-12-11 | Gotoo Yoshoku Kenkyusho:Kk | 水棲動物・陸棲動物用薬剤及び飼料 |
JP3950924B2 (ja) * | 2002-04-18 | 2007-08-01 | 株式会社三重ティーエルオー | 水棲動物に対する有用物質含有リポソームの作製法と投与法 |
TWI347364B (en) * | 2003-02-19 | 2011-08-21 | Novartis Ag | Inactivated nodavirus vaccine |
DE602004006026D1 (de) * | 2003-12-03 | 2007-05-31 | Intervet Int Bv | Streptococcus-phocae-vakzine |
JP4720282B2 (ja) * | 2005-05-06 | 2011-07-13 | 株式会社微生物化学研究所 | 魚類用ワクチン |
-
2008
- 2008-10-30 CL CL2008003262A patent/CL2008003262A1/es unknown
- 2008-10-31 WO PCT/EP2008/064805 patent/WO2009056629A1/en active Application Filing
- 2008-10-31 AU AU2008320818A patent/AU2008320818A1/en not_active Abandoned
- 2008-10-31 CN CN200880113330A patent/CN101868248A/zh active Pending
- 2008-10-31 JP JP2010531535A patent/JP5175940B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
WO2009056629A1 (en) | 2009-05-07 |
JP5175940B2 (ja) | 2013-04-03 |
JP2011502972A (ja) | 2011-01-27 |
AU2008320818A1 (en) | 2009-05-07 |
CN101868248A (zh) | 2010-10-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2008003262A1 (es) | Vacuna que comprende lactococcus garviae, pasteurella piscicida, vibrio anguillarum y nocardia seriolae; y uso de dichas bacterias para combatir infecciones de nocardia en peces. | |
BR112017017805A2 (pt) | composição | |
WO2012062810A3 (en) | Cell culture medium and process for protein expression, said medium and process comprising a pam inhibitor | |
BRPI0807132A2 (pt) | enzimas para o tratamento de lignocelulósicos, ácidos nucléicos que codificam as mesmas, e metodos e uso das mesmas | |
UA107822C2 (en) | Certain triazolopyridines and triazolopyrazines, compositions thereof and methods of use therefor. | |
BR112012018761A2 (pt) | estruturas para prevenir fixação de microorganismos | |
CL2011002852A1 (es) | Uso de bacterias del acido lactico probioticas por un tratamiento con calor para la preparacion de composiciones para prevenir o tratar inmunodeficiencias causadas por infecciones bacterianas, virales, fungicas y/o parasitarias. | |
CL2008003712A1 (es) | Compuestos derivados de tiadiazololoxifenilamidina o tiazoliloxifenilamidina; su procedimiento de preparacion; uso y procedimiento para combatir microorganismos no deseados; agente que comprende a dichos compuestos; compuestos intermediarios; y su procedimiento de preparacion. | |
CO6640205A2 (es) | Microorganismos y metodos para la biosintesis de p-toluato y tereftalato | |
CL2013001134A1 (es) | Composicion de yogurt congelado que comprende microorganismos probioticos no replicantes . | |
CL2008001367A1 (es) | Compuestos derivados de heterociclos nitrogenados sustituidos; procedimiento de preparacion de dichos compuestos; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar una infeccion bacteriana. | |
GB2518813A (en) | OMV vaccine against Burkholderia infections | |
CL2014002348A1 (es) | Compuestos derivados de fenicol; composicion farmaceutica que los comprende; y su uso para controlar o tratar infecciones bacterianas en ganado. | |
ES2570990T3 (es) | Alimento fermentado que contiene bacterias bifidobacterium y método para producir el mismo | |
BR112018074133A2 (pt) | composições de bacillus e métodos de uso com ruminantes | |
BR112012032008A2 (pt) | anticorpos s100a4 e usos terapêuticos do mesmo | |
CL2012002902A1 (es) | Cepas de bacteriofagos especifica contra bacterias pertenecientes al genero vibrio para la profilaxis y terapia de vibrio anguillarum; y composicion antibacteriana que comprende dicha cepas. | |
MX2010000864A (es) | Vacuna de celulas enteras estafilococcicas inactivadas. | |
CL2011002649A1 (es) | Uso de un aerosol que comprende levofloxacina u ofloxacina para preparar un medicamento util para el tratamiento de una infeccion bacteriana pulmonar. | |
CL2008002371A1 (es) | Composicion que comprende un polimero de hebra simple con un motivo arn inmunoestimulante; metodo que comprende poner en contacto una celula inmune capaz de producir interferon alfa con dicho polimero; y metodos para tratar el asma, una condicion alergica, el cancer y una enfermedad infecciosa. | |
BR112012010760A2 (pt) | caldo de fermentação inseticida a partir de actinomicetos | |
UY32488A (es) | Lipasa cpo y derivados de la misma | |
CL2008000856A1 (es) | Uso de una pasteurella multocida mutante acapsular y atenuada para inducir inmunidad protectora cruzada en un animal contra p. multocida virulenta que tiene un serotipo diferente al de p. multocida mutante. | |
BRPI0821025A2 (pt) | Método para tratar biomassa, método para produzir biotanol, uso da composição e biomassa processada. | |
CU20130044A7 (es) | Proceso para la preparación de inhibidores de pan-cdk de fórmula (i), e intermediarios de la preparación |